Richard Ono

VIMAC Ventures LLC (VIMAC Ventures) is a venture capital firm founded in 1982. The firm is headquartered in Boston, Massachusetts.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

The Explorers Club is a professional society founded in 1904 that is dedicated to the advancement of field research, scientific exploration, and resource conservation. The private company is based in New York, NY. Members of the club have explored the earth, seas, skies, and even the moon. The company offers opportunities to carry their historic flag in the field during exploration and supports young explorers from around the world through grants. The official online store of the Explorers Club is available, and the company provides updates on the latest announcements and news related to the club.

Part of Amgen, Inc., IntraImmune Therapies, Inc. develops technologies that allow antibodies to gain access to intracellular targets. The private company is based in Cambridge, MA. The company was founded by Richard Dana Ono. IntraImmune Therapies was acquired by Abgenix, Inc. on November 14, 2000 for $9 million.

VIMAC Milestone Medica Fund LP invests in life science and healthcare companies located in the Eastern US and Canada. The fund targets companies operating in the fields of pharmaceuticals, biotechnology & medical device and cutting-edge products. It provides financing for early and later stage capital requirements with an initial investment size of USD 2 - 3 million and invests up to USD 5 - 7 million per company. It acts as a lead investor.

Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.

The Marine Biological Laboratory provides research and educational services. It offers a range of courses, workshops, conferences, and internships, discovery-based education programs and courses. The firm s a private marine laboratory, supporting scientists and staff working in such fields as cell and developmental biology, ecology, microbiology, molecular evolution, global infectious disease, neurobiology, and sensory physiology. The company was founded in 1888 and is headquartered in Woods Hole, MA.